Vir Biotechnology Inc (VIR)
Interest coverage
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | -684,305 | 833,068 | 420,751 | -296,980 | -177,979 |
| Interest expense | US$ in thousands | — | 183,145 | 272,911 | 3,811 | 7,967 |
| Interest coverage | — | 4.55 | 1.54 | -77.93 | -22.34 |
December 31, 2023 calculation
Interest coverage = EBIT ÷ Interest expense
= $-684,305K ÷ $—K
= —
Unfortunately, without specific data on interest expenses and earnings before interest and taxes (EBIT), we are unable to calculate the interest coverage ratio for Vir Biotechnology Inc for the years presented. Interest coverage ratio is a crucial metric used by investors and creditors to assess a company's ability to meet its interest obligations with its operating profits. It indicates the company's capacity to pay its interest expenses from its operating income. For a more in-depth analysis of Vir Biotechnology Inc's financial health and leverage, access to the specific figures for interest expenses and EBIT is necessary.
Peer comparison
Dec 31, 2023